Astrid Holzinger
Robert Koch Str. 21
Koeln, NW 50931, Germany
Koeln, NW 50931, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
CAR T cells in solid tumors: resistance mechanisms
Journal: Innere Medizin (Heidelberg, Germany)
Published: June 17, 2025
The risk of reactivity against healthy tissues: Novel CARs demand testing for overlooked binding properties.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 10, 2024
Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.
Journal: Journal for immunotherapy of cancer
Published: November 06, 2024
Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma.
Journal: Frontiers in immunology
Published: October 26, 2023
CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation.
Journal: Frontiers in immunology
Published: November 28, 2022
Treatment with Living Drugs: Pharmaceutical Aspects of CAR T Cells.
Journal: Pharmacology
Published: November 13, 2021
Advances and Challenges of CAR T Cells in Clinical Trials.
Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
Published: September 02, 2019
CAR T Cells: A Snapshot on the Growing Options to Design a CAR.
Journal: HemaSphere
Published: October 11, 2018
CAR T Cells in Trials: Recent Achievements and Challenges that Remain in the Production of Modified T Cells for Clinical Applications.
Journal: Human gene therapy
Published: April 06, 2018
CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe target.
Journal: Cancer immunology, immunotherapy : CII
Published: July 06, 2017
Last Updated: 09/26/2026